Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q44564523)
Watch
English
Imatinib mesylate: a major breakthrough in the treatment of chronic myelogenous leukemia
scientific article published in June 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
title
Imatinib mesylate: a major breakthrough in the treatment of chronic myelogenous leukemia
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
main subject
leukemia
1 reference
based on heuristic
inferred from title
imatinib
1 reference
based on heuristic
inferred from title
author
Ali G Turhan
object named as
Ali Turhan
series ordinal
1
0 references
language of work or name
French
0 references
publication date
1 June 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
published in
médecine/sciences
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
volume
19
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
issue
6-7
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
page(s)
667-668
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
Identifiers
DOI
10.1051/MEDSCI/20031967667
0 references
Erudit article ID
20031967667
0 references
PubMed ID
12942435
1 reference
stated in
Europe PubMed Central
PubMed ID
12942435
retrieved
4 December 2017
ResearchGate publication ID
10595295
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit